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Aims. Several mechanisms can be involved in the development of exercise intolerance in patients with heart failure despite normal
left ventricular ejection fraction (HFNEF) and may include impairment of left ventricular (LV) stiﬀness. We therefore investigated
the inﬂuence of LV stiﬀness, determined by pressure-volume loop analysis obtained by conductance catheterization, on exercise
capacity in HFNEF. Methods and results. 27 HFNEF patients who showed LV diastolic dysfunction in pressure-volume (PV) loop
analysis performed symptom-limited cardiopulmonary exercise testing (CPET) and were compared with 12 patients who did
not show diastolic dysfunction in PV loop analysis. HFNEF patients revealed a lower peak performance (P = .046), breathing
reserve (P = .006), and ventilation equivalent for carbon dioxide production at rest (P = .002). LV stiﬀness correlated with peak
oxygen uptake (r =− 0.636, P<. 001), peak oxygen uptake at ventilatory threshold (r =− 0.500, P = .009), and ventilation
equivalent for carbon dioxide production at ventilatory threshold (r = 0.529, P = .005). Conclusions. CPET parameters such as
peak oxygen uptake, peak oxygen uptake at ventilatory threshold, and ventilation equivalent for carbon dioxide production at
ventilatory threshold correlate with LV stiﬀness. Increased LV stiﬀness impairs exercise capacity in HFNEF.
1.Introduction
Recent epidemiological studies have provided evidence that
heart failure despite normal ejection fraction (HFNEF)
accountsformorethan50%ofallheartfailurepatients[1,2].
Their prognosis compares to those of patients suﬀering from
heart failure with reduced ejection fraction [3]. Impaired
exercise tolerance is a main clinical feature of patients
presenting with HFNEF. Several pathophysiological mecha-
nisms have been suggested to be involved in the development
of the clinical scenario that limits physical performance in
HFNEF patients [4]. They include an inadequate increase
of ventricular diastolic ﬁlling and cardiac output during
exercise, consequently leading to pulmonary congestion
[5]. Echocardiographic studies have shown that, in HFNEF
patientsundergoingexercise,anincreasingproportionoflate
diastolic ﬁlling can lead to a drop of the early proportion
of diastolic ﬁlling. A pseudonormalization of the echocar-
diographic transmitral ﬂow pattern at aerobic exercise was
observed indicating a rise in atrial pressure induced by exer-
cise[6].Similarly,elevatedlevelsofNT-proBNP,abiomarker
of heart failure, were veriﬁed in patients who showed normal
ventricular function at rest but elevated ﬁlling pressures at
exercise [7]. Diastolic dysfunction is also associated with
an increased pulmonary blood volume at exercise [8], a
reduced coronary ﬂow reserve at peak-dose dobutamine [9],
an altered breathing pattern characterized by rapid shallow
breaths [10], and a reduced cardiac energetic reserve [11].
Tan et al. [12] found that symptoms are related to an
increased left ventricular (LV) stiﬀness at rest, and in an
invasive, pressure-volume (PV) loop analysis [13]i tw a s
shown that, apart from dyssynchrony and dynamic mitral2 Cardiology Research and Practice
regurgitation, increased LV stiﬀness is a major mechanism
underlying development of HFNEF.
Still,thequestionwhetherincreasedLVstiﬀnessaccounts
for the development of exercise intolerance in HFNEF
patients remains unanswered, since LV stiﬀness has not yet
been measured directly (invasively) when correlating it with
parameters of cardiopulmonary exercise capacity. Therefore,
we aimed to investigate the inﬂuence of LV stiﬀness,
determined by the gold standard method in evaluating
diastolic function, pressure-volume loop analysis obtained
directly by conductance catheterization [14], on cardiac
performance and exercise capacity in HFNEF obtained by
cardiopulmonary exercise testing- (CPET-) derived parame-
ters, commonly used as precise predictors of survival in heart
failure [15, 16].
2. Methods
2.1. Patient Population. We investigated 39 patients admitted
to our department with symptoms of heart failure despite
normal LVEF and suggested diastolic dysfunction. Reasons
for admission were dyspnea, orthopnea or paroxysmal
nocturnaldyspnea,exertionaldyspnea,and/orexerciseintol-
erance. Atrial ﬁbrillation, heart valve disease, signiﬁcant
coronary artery disease, and lung diseases had been excluded
by means of electrocardiogram, laboratory values, angiogra-
phy, echocardiography, chest X-ray, and lung function test.
All patients gave written consent for invasive diagnostic
procedures. The research protocol was approved by the local
institutional review committee.
2.2. Cardiopulmonary Exercise Testing. Symptom-limited
CPET was performed in all patients. β-blockers, ACE-
inhibitors, angiotensin receptor blockers, calcium channel
blockers, and diuretics were withdrawn from the patient’s
medication 24 hours before CPET examination. Heart rate
was measured continuously. Standard 12-lead electrocardio-
grams were obtained at rest, each minute during exercise,
and for at least three minutes during the recovery phase.
Blood pressure was measured using a standard cuﬀ sphyg-
momanometer. Ventilation equivalent for oxygen uptake
(VEO2) and carbon dioxide output (VECO2)a tr e s ta n d
at ventilatory threshold (VEO2 at VT and VECO2 at VT),
peak oxygen uptake at ventilatory threshold (VO2 at VT)
and at peak exercise, peak oxygen uptake per exercise level,
breathing reserve, and breathing frequency were acquired.
Peak VO2 was deﬁned as the highest continuous 30-second
average VO2 occurring within the ﬁnal minute of exercise.
Peak oxygen consumption (VO2 (mL/min/kg)) was acquired
by dividing peak oxygen uptake by the patient’s body weight.
In this study, the ventilatory threshold, a point during
exercise after which ventilation abruptly increases despite
gradual increase in work rate and VO2,w a si d e n t i ﬁ e d
using the ventilation equivalent of oxygen [17]. All tests
were performed with physician supervision. All results were
interpreted by a cardiologist and/or a pneumologist.
2.3. PV Measurements by Conductance Catheter Method.
Three to ﬁve days after the CPET investigations, PV
measurements were performed, as previously described
in [14]. β-blockers, ACE-inhibitors, angiotensin receptor
blockers, calcium channel blockers, and diuretics were
withdrawnfromthepatient’smedication24hoursbeforethe
examination.
Theconductancecatheterallowscontinuousonlinemea-
surements of LV pressure and volume [18]. A 7F combined
pressure-conductance catheter (CD Leycom, Zoetermeer,
The Netherlands) was introduced retrogradely into the LV
by standard methods and connected to a cardiac function
laboratory (CD Leycom) for acquisition of the LV vol-
ume, pressure, and ECG. Total LV volume was calibrated
with thermodilution and hypertonic saline dilution [19].
Hemodynamic indexes were obtained from steady-state
PV loops at sinus rhythm. PV relationships were then
derived from PV loops recorded during preload reduction
through temporary balloon occlusion (NuMED, Hopkinton,
NY, USA) of the inferior vena cava. Cardiac performance
was assessed by heart rate, stroke volume, end-diastolic
volume, end-systolic volume, cardiac output, and stroke
work. Systolic load-dependent LV function was determined
by EF, end-systolic pressure, and maximum rate of pressure
change (dP/dtmax). Diastolic load-dependent LV function
was assessed by LV end-diastolic pressure (LVEDP), LV
minimal pressure (LVPmin), isovolumetric relaxation time
constant (τ), minimal rate of LV pressure change (dP/dtmin),
and maximum rate of LV ﬁlling (dV/dtmax). We calculated
the average slope of the end-diastolic PV relationship
(dP/dV) to determine functional LV chamber stiﬀness and
the exponential curve ﬁt to the diastolic LV PV points
to determine how rapidly stiﬀness (dP/dV) increases with
increasing pressure (LV stiﬀness constant, β). Increased LV
stiﬀness was considered present if β (≥0.015mL−1)w a s
increased in clinically symptomatic patients despite normal
EF, as described previously in [14].
2.4. Echocardiography. Three to ﬁve hours before the PV-
loopmeasurementwasperformed,echocardiographystudies
had been performed by 2 independent investigators who
were blinded to all information derived from CPET analyses.
Mitral ﬂow velocities were recorded in the apical 4-
chamber view with a VingMed System FiVe (GE Healthcare,
Chalfont St. Giles, UK). The LVEF was calculated from
two-dimensional apical images according to the Simpson
method. The LV mass was calculated according to the
formula proposed by Devereux and divided by body surface
area for LV mass index calculation [20]. Mitral inﬂow
measurements included peak early (E) and peak late (A)
ﬂow velocities, the E/A ratio, the deceleration time of early
mitralﬂowvelocity(DT),andtheisovolumicrelaxationtime
(IVRT). Data were adjusted for age and heart rate according
to guidelines [21]. Chamber dimensions were evaluated
usingstandardprocedures,includingLVmassindex[20]and
left atrial (LA) diameter.
T h et i s s u eD o p p l e ro ft h em i t r a la n n u l u sm o v e m e n t
was obtained from the apical 4-chamber view. A 1.5-mm
sample volume was placed sequentially at the lateral and
septal annular sites. The analysis was performed for systolic
(S ), early diastolic (E ), and late diastolic (A )p e a kt i s s u eCardiology Research and Practice 3
velocities. As a noninvasive parameter for LV stiﬀness, the LV
ﬁllingindex(E/E ),calculatedbytheratiooftransmitralﬂow
velocity to annular velocity, was determined [22]. Adequate
mitral and TDI signals were recorded in all patients.
2.5. Statistical Analysis. SPSS software for Macintosh OS
(Version 18, SPSS Inc., Chicago, Ill, USA) was used for
statistical analysis. Descriptive characteristics of continuous
variables were expressed as median values with the ﬁrst
and third quartiles. Correlation analyses between CPET,
echocardiographic, and PV-loop indexes were provided
using linear regression model. Comparisons between groups
were performed with ANOVA if variables were normally
distributed the Mann-Whitney U test if the data were
not normally distributed, and Pearson’s χ2 test was used
to analyze categorical variables. A value of P<. 05 was
consideredstatisticallysigniﬁcantinallanalyses.Theauthors
had full access to and take full responsibility for the integrity
of the data. All authors have read and agreed to the
manuscript as written.
3. Results
3.1. Patient Characteristics. Population characteristics, heart
dimensions, and concomitant diseases are presented in
Table 1. According to the results from the end-diastolic
pressure volume relationship patients were divided into 2
groups: those with impaired EDPVR as characterized by
increased LV stiﬀness indicating diastolic heart failure (DHF,
n = 27) and those with normal EDPVR (noDHF, n = 12).
With respect to gender, age, race, and body mass index
there were no signiﬁcant diﬀerences between the subgroups.
There was a tendency towards higher prevalences of arterial
hypertension (48% versus 17%), diabetes mellitus (19%
versus8%),obesity(37%versus17%),hyperlipoproteinemia
(26% versus 17%), and nicotine abuse (19% versus 17%) in
the DHF group, but statistically signiﬁcant diﬀerences were
not found.
3.2. Heart Dimensions and LV Diastolic Properties. As pre-
sented in Table 1, all investigated patients showed normal
heart dimensions. There were no signiﬁcant diﬀerences
between the groups regarding LV mass, LA diameter, and LV
end-diastolic diameter. LV mass index tended to be higher
in HFNEF patients with increased LV stiﬀness. LA diameter
correlated with τ (r = 0.473, P = .005).
3.3. Cardiac Performance, Systolic Function, and LV Contrac-
tility. According to PV loop analysis and echocardiographic
parameters, both conventional and TDI derived, there were
no signiﬁcant diﬀerences in heart rate, end-systolic pressure,
end-systolic volume, stroke volume, stroke work, cardiac
output, LVEF, and myocardial systolic velocities (S  sep,
S  lat), as presented in Tables 2 and 3.L Vc o n t r a c t i l i t y
(dP/dtmax) was lower in patients with an increased LV
stiﬀness (P = .026, Table 2).
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Figure 1: Relationship between peak oxygen consumption and
groups deﬁned by LV stiﬀness. Thick vertical lines represent mean
and thin vertical lines represent standard deviation, P<. 001.
3.4. LV Diastolic Function. Table 2 presents diastolic indexes
provided by conductance catheter-derived PV loop analysis.
Patients with increased LV stiﬀness showed a prolonged τ
(P = .001) and a lower dP/dtmin (P = .007). Their LVEDP
was signiﬁcantly increased (P<. 001), whereas EDV did not
diﬀer signiﬁcantly.
Conventional echocardiographic and TDI diastolic
parameters are shown in Table 3. Peak late mitral inﬂow
(A) was signiﬁcantly higher in patients with increased LV
stiﬀness (P = .013). The septal and lateral LV ﬁlling
index (E/E ) was signiﬁcantly higher in the DHF group
(P<. 001, and P = .007, resp.). DHF patients showed
a signiﬁcantly decreased early diastolic peak velocity (E ).
No patient showed a pseudonormal or restrictive ﬁlling
pattern. The E/Aratio tended to be lower in HFNEF patients
with increased LV stiﬀness, but the diﬀerence did not reach
statistical signiﬁcance. Echocardiographic ﬁndings showed
mild diastolic dysfunction in patients with increased LV
stiﬀness,indicatedbyaslightlyelevatedLVﬁllingindex(E/E 
sep 10.83 (8.40–16.05), E/E  lat 8.69 (6.62–13.46)) and a
normal E/A ratio (1.21 (1.01–1.51)).
3.5. CPET and LV Stiﬀness, Ejection Fraction, and Systolic
Indexes. CPET ﬁndings are presented in Table 4.W i t h
normal LV stiﬀness with respect to heart rate at peak
exercise, breathing frequency, VEO2 at rest, VEO2 at ven-
tilatory threshold, and VECO2 at ventilatory threshold
there were no signiﬁcant diﬀerences between patients with
increased LV stiﬀness and subjects. HFNEF patients, in
whom LV stiﬀness was increased according to PV loop
analysis, showed signiﬁcantly decreased exercise tolerance
indicated by a decreased peak performance, as well as
signiﬁcantly decreased breathing reserve, signiﬁcantly lower
peak oxygen consumption (16mL/min/kg (14mL/min/kg–
19mL/min/kg) versus 21.5mL/min/kg (18.5mL/min/kg–
27mL/min/kg), P<. 001, Figure 1), and signiﬁcantly higher
ventilation equivalent values for carbon dioxide output at
rest and at ventilatory threshold (Table 4). As shown in4 Cardiology Research and Practice
Table 1: Patient Characteristics (variable expressed as median [25–75% quartile]).
Patient population
(n = 39)
DHF
(n = 27)
noDHF
(n = 12)
P
Demographics:
Men, n (%) 16 (41) 11 (41) 5 (42) .957
Age, y 50 [38–60] 54 [41–60] 41 [36–52] .113
BMI, kg/m2 24 [22–32] 25 [22–33] 23 [21–28] .083
NYHA class II/III, n (%) 21/18 10 (36)/17 (63) 11 (92)/1 (8)
Concomitant disease
Art. hypertension, n (%) 15 (38) 13 (48) 2 (17) .062
Diabetes mellitus, n (%) 6 (15) 5 (19) 1 (8) .416
Obesity, n (%) 12 (31) 10 (37) 2 (17) .203
Hyperlipoproteinemia, n (%) 9 (23) 7 (26) 2 (17) .526
Smoker, n (%) 7 (18) 5 (19) 2 (17) .889
Heart dimensions
LA, mm 34 [31–38] 34 [30–40] 35 [32–36] .882
LVEDD, mm 48 [45–52] 48 [45–52] 48 [46–51] .708
Septum, mm 10 [10-11] 10 [10–13] 10 [9–11] .155
Posterior wall, mm 10 [9–11] 11 [9–13] 10 [9–11] .076
LV mass, g 173 [140–225] 173 [125–225] 172 [145–200] .503
LVMI, g/m2 96 [76–105] 96 [74–117] 91 [75–97] .281
BMI indicates body mass index, NYHA New York Heart Association class, LA left atrial parasternal diameter, LVEDD LV end-diastolic diameter, and LVMI
LV mass index.
Figure 2, exercise capacity, indicated by peak performance,
correlated with the degree of LV stiﬀness not only in all
patients (r =− 0.487, P = .002) but also within the
groups of patients who had been diagnosed with increased
LV stiﬀness (r =− 0.518, P = .006). As presented in Figure 3,
CPET parameters of cardiopulmonary function peak VO2
((mL/min/kg),r =− 0.427, P = .007), O2 pulse(r =− 0.366,
P = .022), peak VO2 at ventilatory threshold (r =− 0.489,
P = .002), VEO2 at rest (r = 0.380, P = .017), VEO2 at
ventilatorythreshold(r = 0.452,P = .005),aswellasVECO2
at rest (r = 0.521, P = .001), VECO2 at ventilatory threshold
(r = 0.569, P<. 001), and breathing reserve (r =− 0.353,
P = .028) correlated with LV stiﬀness in all patients, whereas
breathing frequency did not show a signiﬁcant correlation
with LV stiﬀness (r =− 0.073, P = .658). Also, heart rate
at peak exercise (r =− 0.309, P = .056), breathing frequency
(r =− 0.073, P = .658), and peak oxygen uptake per exercise
level (r =− 0.047, P = .778) did not correlate signiﬁcantly
with the degree of LV stiﬀness determined by PV loop
analysis obtained directly by conductance catheterization.
Ejection fraction (r =− 0.023, P = .889), ESP (r =− 0.101,
P = .541),andmyocardialcontractility(dP/dtmax,r = 0.206,
P = .209) did not show a signiﬁcant correlation with exercise
capacity indicated by CPET-derived peak performance.
4. Discussion
Thisstudyistheﬁrsttodatetoinvestigatethedirectinﬂuence
of LV stiﬀness, determined by PV loop analysis [13, 14],
on exercise capacity, determined by CPET, in patients with
HFNEF. We show that exercise capacity correlates with the
degree of LV stiﬀness.
CPET represents a widespread method for evaluation of
exercise capacity in patients with heart failure symptoms
despite normal ejection fraction (HFNEF). Disturbed LV
stiﬀness is considered a cardinal mechanism of diastolic
dysfunction [23] and therefore may contribute to exercise
intolerance in health and HF patients [24]. In healthy
subjects, the strong and independent association between
exercise capacity and resting LV ﬁlling pressures assessed by
echocardiography has been demonstrated [25]. In hyper-
trophic cardiomyopathy, a signiﬁcant correlation between
LA fractional shortening, an index of passive diastolic ﬁlling,
and both the ventilatory threshold and peak VO2 has
been found [26]. These ﬁndings reported LA fractional
shortening and pulmonary systolic ﬁlling fraction to be the
only independent predictors of exercise capacity, suggesting
that, in the setting of hypertrophic cardiomyopathy, exercise
tolerance is determined rather by diastolic than by systolic
function.
In our study, HFNEF patients with increased LV stiﬀ-
ness showed a signiﬁcantly impaired exercise tolerance
and breathing reserve, as well as signiﬁcantly increased
ventilation equivalents for carbon dioxide output at rest
and at ventilatory threshold. In this comparably young
DHF population, there were no appearances of hypertrophic
cardiomyopathy, hypertrophic obstructive cardiomyopathy,
and/or pseudonormalization. We were still able to show that
exercise intolerance is linked to an increased LV stiﬀness in
this population.Cardiology Research and Practice 5
Table 2: PV measurements by Conductance Catheter Method (variable expressed as median [25%–75% quartile]).
Patient population
(n = 39)
DHF
(n = 27)
noDHF
(n = 12)
P
Heart rate, bpm 79 [68–88] 75 [68–88] 81 [70–87] .648
Systolic indexes
ESP, mmHg 121 [112–138] 130 [112–144] 117 [113–121] .094
ESV, mL 56 [31–85] 57 [30–84] 53 [34–88] .903
SV, mL 100 [79–121] 95 [68–122] 105 [81–120] .584
SW, mmHg ∗ mL 9813 [7434–12542] 9614 [7120–12542] 11323 [7526–14136] .411
CO, mL/min 7183 [5956–9423] 7183 [5224–9414] 7365 [6276–10125] .338
dP/dtmax, mmHg/s 1447 [1337–1695] 1429 [1275–1590] 1584 [1425–1777] .026
LVEF, % 65 [55–70] 65 [60–70] 69 [60–77] .353
Diastolic indexes
EDV, mL 141 [107–190] 141 [99–194] 149 [110–178] .927
LVEDP, mmHg 10 [8–14] 12 [11–18] 7 [6–10] <.001
dP/dtmin, mmHg/s −1827
[(−2037)–(−1589)]
−1715
[(−1937)–(−1486)]
−1979
[(−2170)–(−1883)]
.007
τ,m s 50 [43–60] 54 [47–62] 45 [40–48] .001
Stiﬀness β,1 / m L 0.018 [0.011–0.028] 0.027 [0.016–0.036] 0.011 [0.009–0.012] .001
ESP indicates end-systolic pressure, ESV end-systolic volume, SV stoke volume, SW stroke work, CO cardiac output, dP/dtmax maximum rate of pressure
change, LVEF left ventricular ejection fraction, EDV end-diastolic volume, LVEDP LV end-diastolic pressure, dP/dtmin minimal rate of LV pressure change, τ
isovolumetric relaxation time, Stiﬀness constant β exponential curve ﬁt to end-diastolic PV relationship, and Stiﬀness b slope of end-diastolic PV relationship
(dP/dV).
Table 3: Indices of conventional and TDI echocardiography (variable expressed as median [25–75% quartile]).
Patient population
(n = 39)
DHF
(n = 27)
noDHF
(n = 12)
P
LVEF, % 62 [55–70] 61 [53–69] 63 [55–73] .512
Mitral ﬂow
E,m / s 0.81 [0.69–0.96] 0.87 [0.73–1.02] 0.7 [0.6–0.85] .036
A,m / s 0.66 [0.51–0.76] 0.7 [0.6–0.8] 0.56 [0.42–0.7] .013
E/A 1.25 [1.05–1.51] 1.21 [1.01–1.51] 1.29 [1.17–1.52] .424
DT, ms 179 [139–211] 185 [142–224] 180 [156–190] .412
IVRT, ms 91 [85–103] 92 [85–110] 91 [88–97] .591
TDI
S  sep, m/s 0.05 [0.04–0.08] 0.06 [0.04–0.08] 0.05 [0.04–0.07] .752
E  sep, m/s 0.09 [0.08–0.12] 0.09 [0.05–0.09] 0.12 [0.11–0.13] .001
A  sep, m/s 0.06 [0.05–0.07] 0.06 [0.04–0.07] 0.06 [0.05–0.07] .712
E/E  sep 8.46 [6.55–13.08] 10.83 [8.40–16.05] 5.98 [4.76–6.88] <.001
S  lat, m/s 0.05 [0.04–0.07] 0.05 [0.04–0.07] 0.05 [0.04–0.08] .958
E  lat, m/s 0.11 [0.08–0.13] 0.1 [0.06–0.12] 0.12 [0.08–0.14] .139
A  lat, m/s 0.04 [0.03–0.07] 0.05 [0.03–0.07] 0.04 [0.03–0.07] .792
E/E  lat 7.6 [6.26–9.8] 8.69 [6.62–13.46] 6.26 [5.39–7.56] .007
LVEF indicates left ventricular ejection fraction; E/A,r a t i oo fe a r l y( E)t ol a t e( A) mitral ﬂow peak velocities; DT, deceleration time of early mitral ﬂow; IVRT,
isovolumetric relaxation time; S ,s y s t o l i c ;E ,e a r l y ;a n dA , late diastolic peak velocities of mitral annulus at lateral site; E /A ,r a t i oo fE  to A ; E/E ,L V
ﬁlling index; sep, septal; lat, lateral.
4.1. LV Diastolic Function and Heart Dimensions. Our DHF
patients,whowerecharacterizedbyanalmost3-foldincrease
inLVstiﬀness(median:0.027mL−1),showedanonlymoder-
ately increased LVEDP at rest (median: 12mmHg, Table 2).
In addition, LA diameters in the DHF group were almost the
same as those in the noDHF group, ranging within normal
limits. This ﬁnding is in agreement with the short duration
of heart failure symptoms in our relatively young population
( m e d i a na g e :5 4v e r s u s4 1y e a r s ,P = .113), where structural
LV remodeling on myocardial structure, as proposed by6 Cardiology Research and Practice
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Figure 2: Linear regression between peak performance and LV stiﬀness in all patients (above, n = 39) and in HFNEF patients with increased
LV stiﬀness (below, n = 27). Stiﬀness beta indicates exponential curve ﬁt to end-diastolic PV relationship, r correlation coeﬃcient, and P
signiﬁcance level.
Table 4: Indices of cardiopulmonary exercise testing (variable expressed as median [25–75% quartile]).
Patient population
(n = 39)
DHF
(n = 27)
noDHF
(n = 12)
P
Performance, watt 117 [90–159] 108 [87–146] 148 [103–196] .046
Heart rate, 1/min 138 [119–162] 133 [112–148] 150 [128–166] .110
VO2, mL/min/kg 18 [16–20] 16 [14–19] 21.5 [18.5–27] <.001
O2 pulse, mL/beat 11.6 [9.2–13.2] 11.6 [9.2–13] 11.5 [9–13.5] .715
VO2/exercise level, mL/min/Watt 9.6 [8.4–10.8] 9.7 [8.3–11.5] 9.2 [8.4–9.8] .161
Breathing reserve, L 64 [42–83] 57 [37–72] 81 [74–98] .006
Breathing frequency, 1/min 32 [29–37] 32 [29–37] 31 [25–40] .502
VO2 at VT, L/min 0.96 [0.75–1.25] 0.94 [0.72–1.13] 1.03 [0.82–1.39] .172
Ventilation equivalents
VECO2 at rest 40 [37–46] 43 [39–49] 37 [34–39] .002
VECO2 at VT 31 [30–33] 33 [30–36] 31 [24–33] .023
VEO2 at rest 34 [32–37] 35 [32–39] 34 [29–36] .138
VEO2 at VT 31 [29–35] 31 [29–35] 31 [23–34] .423
VO2 indicatespeakoxygenuptake,VTventilatorythreshold,VECO2 ventilationequivalentforcarbondioxideoutput,VEO2 ventilationequivalentforoxygen
uptake.
Van Heerebeek et al. [27], is still moderate. Moreover,
catheter measurements were performed in clinical stable
patients after recompensation using diuretics, which may
havealteredLVEDP.Accordingtoourpreviousﬁndings[22],
DHF patients were characterized by an elevated and signiﬁ-
cantly higher echocardiographic LV ﬁlling index compared
with the noDHF group, who showed a normal LV ﬁlling
index.
4.2. CPET and LV Stiﬀness. Several studies have already dis-
cussed the association of reduced exercise capacity and dias-
tolic function, as suggested by echocardiographic analysisCardiology Research and Practice 7
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Figure 3: Linear regression between CPET indices and LV stiﬀness in all patients. VO2 indicates peak oxygen uptake, VT ventilatory
threshold,VECO2 ventilationequivalentforcarbondioxideoutput,VEO2 ventilationequivalentforoxygenuptake,stiﬀnessbetaexponential
curve ﬁt to end-diastolic PV relationship, r correlation coeﬃcient, and P signiﬁcance level.
[24, 28, 29]. However, the pathomechanism responsible
for the main clinic limitation of those patients—exercise
intolerance—remains unclear. It is particularly diﬃcult to
divide pulmonary limitations or training deﬁciency from
cardiac dysfunction.
I nar e c e n th e a rtf a i l u r es t u d y ,A r r u d ae ta l .[ 28]r e p o rt e d
that, among 40 patients with diastolic dysfunction and
46 patients with systolic dysfunction, LA volume highly
correlated with exercise capacity, breathing pattern, and gas
exchange during exercise in the diastolic dysfunction patient
group. In the same study no signiﬁcant diﬀerences between
the diastolic dysfunction and the systolic dysfunction group
regarding breathing pattern and gas exchange parameters
were described, which is in agreement with the ﬁndings of
Kitzman et al. [24], who reported a similar peak exercise
VE/VCO2 ratio in patients suﬀering from diastolic heart
failure and in patients suﬀering from systolic heart failure.
We now extend this knowledge by correlating parameters of
exercise capacity and gas exchange with invasively measured
parameters of diastolic dysfunction in a relatively young
HFNEF population, which was stable at rest. We found
correlations between LV stiﬀness and VO2 at VT, VEO2 at
rest, VEO2 at VT, VCO2 at rest, VECO2 at VT, breathing
reserve, and peak performance on CPET (Figures 2 and
3). This validates the concept of impaired diastolic cardiac
function, characterized by increased LV stiﬀness, accounting
for exercise intolerance in HFNEF patients. Our data suggest
that increased LV stiﬀness, leading to pulmonary congestion
and, consecutively, an impaired breathing reserve, represents
the main pathomechanism underlying the development of
dyspnea on exertion in HFNEF patients.
It has been suggested that impaired diastolic ﬁlling may
lead to restrictive pulmonary changes, which contribute
to a limited increase of the tidal volume during exercise
and, because of ﬁx dead space ventilation taking up greater
percentage of the tidal breath, higher VECO2 values [28].
Of all investigated CPET parameters the highest correlation
was found between LV stiﬀness and VECO2 at VT (r =
0.569, P<. 001). CPET-derived VECO2 at VT may therefore
be a helpful parameter in the noninvasive estimation of
LV stiﬀness and diastolic dysfunction at an early stage,
given the relatively young age and comparably mild changes
of diastolic echocardiographic parameters in our patient
population.
In a recent noninvasive study [12], Tan et al. examined
the pathophysiological mechanisms of HFNEF by exercise
echocardiography. They elegantly show that a combination
ofreducedmyocardialstrain,rotation,LVsuction,longitudi-
nal function, and delayed LV untwisting rather than elevated
LV stiﬀness alone causes symptoms in HFNEF. However,
the correlation of invasively measured LV stiﬀness and
CPET parameters in this study underlines the importance
of LV stiﬀness as a predictor of exercise intolerance in
HFNEF.
I n c r e a s e dL Vs t i ﬀness correlates with alterations in
exercise performance, gas exchange, and breathing pattern
duringexercise.Inthisstudypopulation, HFNEFpatients,in
whom increased LV stiﬀness indicating DHF is present, show
signiﬁcantly lower cardiopulmonary performances at CPET.
Several CPET parameters of cardiac capacity, such as oxygen
consumption and VECO2 at VT, correlate signiﬁcantly with
left ventricular stiﬀness obtained by conductance catheter-
derived PV loop analysis. Impaired diastolic cardiac func-
tion, characterized by impairment in LV stiﬀness, plays an
important role in determining exercise capacity in HFNEF
patients with diastolic dysfunction.Cardiology Research and Practice 9
Abbreviations and Acronyms
A: L a t ep e a km i t r a lﬂ o wv e l o c i t y
A : Late velocity of mitral annulus
ACE: Angiotensin-converting enzyme
b:L V s t i ﬀness b, slope of EDPVR (dP/dV)
β: Constant of LV stiﬀness, exponential curve
ﬁt to EDPVR
c: Curve ﬁtting constant
CO: Cardiac output
CPET: Cardiopulmonary exercise testing
DHF: Diastolic heart failure
dP/dtmax: Maximum rate of LV pressure change
dP/dtmin: Minimum rate of LV pressure change
E: Early peak mitral ﬂow velocity
E : Early diastolic velocity of mitral annulus
E/A: Ratio of early peak (E)t ol a t ep e a k( A)
mitral ﬂow velocities
E/E : LV ﬁlling index
E /A :E a r l y ( E )t ol a t e( A ) diastolic velocity ratio
of mitral annulus
EDV: End-diastolic volume
EDPVR: End-diastolic pressure-volume relationship
EF: Ejection fraction
ESP: End-systolic pressure
ESPVR: End-systolic pressure-volume relationship
ESV: End-systolic volume
HFNEF: Heart failure with preserved ejection fraction
IVRT: Isovolumetric relaxation time
LA: Left atrial
LAVI: Left atrial volume index
LV: Left ventricular
LVEDP: LV end-diastolic pressure
LVMI: LV mass index
LVPmin: LV minimal pressure
PV: Pressure volume
S : Systolic velocity of mitral annulus
SW: Stroke work
τ: Isovolumetric relaxation time constant
TDI: Tissue Doppler imaging
VCO2: Peak carbon dioxide output
VE: Ventilation equivalent
VO2: P e a ko x y g e nu p t a k e
VT: Ventilatory threshold.
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